These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Usefulness of progressive inhomogeneity of myocardial perfusion and chronotropic incompetence in detecting cardiac allograft vasculopathy: evaluation with dobutamine thallium-201 myocardial SPECT. Wu YW; Yen RF; Lee CM; Ho YL; Wang SS; Hsu RB; Chou NK; Huang PJ Cardiology; 2005; 104(3):156-61. PubMed ID: 16127274 [TBL] [Abstract][Full Text] [Related]
25. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy. Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667 [TBL] [Abstract][Full Text] [Related]
32. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response. van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796 [TBL] [Abstract][Full Text] [Related]
33. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease. Jonas M; Fang JC; Wang JC; Giri S; Elian D; Har-Zahav Y; Ly H; Seifert PA; Popma JJ; Rogers C J Am Coll Cardiol; 2006 Aug; 48(3):453-61. PubMed ID: 16875968 [TBL] [Abstract][Full Text] [Related]
35. Human ApoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells. Feng Y; Jacobs F; Van Craeyveld E; Brunaud C; Snoeys J; Tjwa M; Van Linthout S; De Geest B Arterioscler Thromb Vasc Biol; 2008 Feb; 28(2):278-83. PubMed ID: 18063807 [TBL] [Abstract][Full Text] [Related]
36. Non-invasive diagnostic of cardiac allograft vasculopathy by 31P magnetic resonance chemical shift imaging. Caus T; Kober F; Marin P; Mouly-Bandini A; Quilici J; Métras D; Cozzone PJ; Bernard M Eur J Cardiothorac Surg; 2006 Jan; 29(1):45-9. PubMed ID: 16343922 [TBL] [Abstract][Full Text] [Related]
37. The University of California at Los Angeles heart transplantation experience. Kobashigawa JA; Laks H; Wu G; Patel J; Moriguchi J; Hamilton M; Fonarow G; Fishbein M; Ardehali A Clin Transpl; 2005; ():173-85. PubMed ID: 17424734 [TBL] [Abstract][Full Text] [Related]
38. Comparison of sixty-four-slice multidetector computed tomographic coronary angiography to coronary angiography with intravascular ultrasound for the detection of transplant vasculopathy. Gregory SA; Ferencik M; Achenbach S; Yeh RW; Hoffmann U; Inglessis I; Cury RC; Nieman K; McNulty IA; Laffan JA; Pomerantsev EV; Brady TJ; Semigran MJ; Jang IK Am J Cardiol; 2006 Oct; 98(7):877-84. PubMed ID: 16996866 [TBL] [Abstract][Full Text] [Related]
39. Influence of traditional cardiovascular risk factors in the recipient on the development of cardiac allograft vasculopathy after heart transplantation. Sánchez Lázaro IJ; Almenar Bonet L; Moro López J; Sánchez Lacuesta E; Martínez-Dolz L; Agüero Ramón-Llín J; Andrés Lalaguna L; Cano Pérez O; Ortiz Martínez V; Buendía Fuentes F; Salvador Sanz A Transplant Proc; 2008 Nov; 40(9):3056-7. PubMed ID: 19010192 [TBL] [Abstract][Full Text] [Related]
40. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients. Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]